How many insider trades does FilingIQ track for CODX?

FilingIQ tracks 162 Form 4 insider transactions for CODX (Co-Diagnostics, Inc.), covering filings from Sep 19, 2017 onwards. 17 of those were filed in the last 90 days.

Are CODX insiders net buyers or net sellers?

Across the full Form 4 history for CODX, 7 transactions (4%) were open-market purchases and 22 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CODX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CODX in?

Co-Diagnostics, Inc. (CODX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $6.79M.

CODX insider trading

OTC Markets OTCPK Healthcare

Co-Diagnostics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

162

Last 90 days

Buys / sells

4% / 14%

Market cap

$6.79M

About Co-Diagnostics, Inc.

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

Company website: co-dx.com

CODX insider activity at a glance

FilingIQ has scored 162 insider transactions for CODX since Sep 19, 2017. The most recent filing in our index is dated May 23, 2026.

Across the full history, 7 open-market purchases and 22 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CODX insider trades is 60.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CODX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,265

UNITED THERAPEUTICS Corp

APLS 277

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 195

Guardant Health, Inc.

ADPT 184

Adaptive Biotechnologies Corp

BMY 182

BRISTOL MYERS SQUIBB CO

VTRS 165

Viatris Inc

ALNY 153

ALNYLAM PHARMACEUTICALS, INC.

Frequently asked

How many insider trades does FilingIQ track for CODX?: FilingIQ tracks 162 Form 4 insider transactions for CODX (Co-Diagnostics, Inc.), covering filings from Sep 19, 2017 onwards. 17 of those were filed in the last 90 days.
Are CODX insiders net buyers or net sellers?: Across the full Form 4 history for CODX, 7 transactions (4%) were open-market purchases and 22 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CODX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CODX in?: Co-Diagnostics, Inc. (CODX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $6.79M.

Methodology & sources

Every CODX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.